232 related articles for article (PubMed ID: 7923689)
41. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Thibault G; Haass M; Höhnel K; Bohlender J; Luft FC; Dietz R
Cardiovasc Res; 1999 Jun; 42(3):733-42. PubMed ID: 10533614
[TBL] [Abstract][Full Text] [Related]
43. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA
Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633
[TBL] [Abstract][Full Text] [Related]
44. Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan.
Wang J; Guo X; Dhalla NS
Biochim Biophys Acta; 2004 Oct; 1690(2):177-84. PubMed ID: 15469907
[TBL] [Abstract][Full Text] [Related]
45. Regression of left ventricular hypertrophy in experimental renovascular hypertension: diastolic dysfunction depends more on myocardial collagen than it does on myocardial mass.
Dussaillant GR; Gonzalez H; Cespedes C; Jalil JE
J Hypertens; 1996 Sep; 14(9):1117-23. PubMed ID: 8986913
[TBL] [Abstract][Full Text] [Related]
46. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
47. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
Ritter JM; Cockcroft JR; Sciberras DG; Goldberg MR
J Hypertens Suppl; 1993 Apr; 11(3):S59-61. PubMed ID: 8391072
[TBL] [Abstract][Full Text] [Related]
48. Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats.
Mill JG; Milanez Mda C; de Resende MM; Gomes Mda G; Leite CM
Clin Exp Pharmacol Physiol; 2003 Oct; 30(10):739-44. PubMed ID: 14516412
[TBL] [Abstract][Full Text] [Related]
49. Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats.
Baba HA; Iwai T; Bauer M; Irlbeck M; Schmid KW; Zimmer HG
J Mol Cell Cardiol; 1999 Feb; 31(2):445-55. PubMed ID: 10093056
[TBL] [Abstract][Full Text] [Related]
50. Regulation of fibrillar collagen gene expression and protein accumulation in volume-overloaded cardiac hypertrophy.
Namba T; Tsutsui H; Tagawa H; Takahashi M; Saito K; Kozai T; Usui M; Imanaka-Yoshida K; Imaizumi T; Takeshita A
Circulation; 1997 May; 95(10):2448-54. PubMed ID: 9170409
[TBL] [Abstract][Full Text] [Related]
51. Arterial vasodilators, cardiac volume load, and cardiac hypertrophy in normotensive rats.
Tsoporis J; Yuan BX; Leenen FH
Am J Physiol; 1989 Mar; 256(3 Pt 2):H876-80. PubMed ID: 2522286
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content.
Smits JF; van Krimpen C; Schoemaker RG; Cleutjens JP; Daemen MJ
J Cardiovasc Pharmacol; 1992; 20(5):772-8. PubMed ID: 1280740
[TBL] [Abstract][Full Text] [Related]
53. Effects of differential blockade of the renin-angiotensin system in postinfarcted rats.
Lacour C; Roccon A; Galindo G; Canals F; Hogie M; Segondy D; Briand D; Roque C; Herbert JM; Nisato D
Fundam Clin Pharmacol; 2004 Jun; 18(3):299-307. PubMed ID: 15147281
[TBL] [Abstract][Full Text] [Related]
54. Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes.
Machackova J; Liu X; Lukas A; Dhalla NS
Mol Cell Biochem; 2004 Jun; 261(1-2):271-8. PubMed ID: 15362513
[TBL] [Abstract][Full Text] [Related]
55. The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II.
De Mello W; Altieri P
J Cardiovasc Pharmacol; 1992 Oct; 20(4):643-51. PubMed ID: 1280722
[TBL] [Abstract][Full Text] [Related]
56. Impact of early life AT
Poletto Bonetto JH; Fernandes RO; Dartora DR; Flahault A; Sonea A; He Y; Cloutier A; Belló-Klein A; Nuyt AM
Eur J Pharmacol; 2019 Oct; 860():172585. PubMed ID: 31376367
[TBL] [Abstract][Full Text] [Related]
57. Altered effects of angiotensin ii type 1 and type 2 receptor blockers on cardiac norepinephrine release and inotropic responses during cardiac sympathetic nerve stimulation in aorto-caval shunt rats.
Suzuki H; Maehara K; Yaoita H; Maruyama Y
Circ J; 2004 Jul; 68(7):683-90. PubMed ID: 15226636
[TBL] [Abstract][Full Text] [Related]
58. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
Pollock DM; Divish BJ; Polakowski JS; Opgenorth TJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):657-63. PubMed ID: 8246138
[TBL] [Abstract][Full Text] [Related]
59. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
[TBL] [Abstract][Full Text] [Related]
60. Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats.
Keith DS; Torres VE; Johnson CM; Holley KE
Am J Kidney Dis; 1994 Sep; 24(3):491-8. PubMed ID: 8079975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
